Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
723.00    7.00 (0.98%)
Bid:
722.00
Ask:
724.00
Spread: 2.00 (0.277%)
Market Cap: £695.00m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Acquisition

12 Jan 2011 07:00

RNS Number : 3039Z
Acal PLC
12 January 2011
Β 

ο»Ώ

For Release

7.00am, 12 January 2011

Β 

Acal plc

Β 

Acal Strengthens Electronics Division with the Acquisition of

a German Specialist Electronics business

Β 

Acal plc (LSE: ACL, "The Group"), the pan European specialist provider of technology services, is pleased to announce the acquisition of 100% of CompoTRON GmbH ("CompoTRON"), for a maximum consideration of Β£7.1m (€8.5m) before expenses. CompoTRON has been acquired from BW-Holding GmbH, a company wholly owned by the CompoTRON management, Mr W Brack and Ms B Lohmaier.

CompoTRON is a specialist provider of electronic communication and fibre optic components to the European industrial electronic markets. Based in Munich with operations in Germany, the UK and Denmark, CompoTRON employs 22 staff. The company will form a separate business unit within Acal's Electronics division and will retain its strong independent brand identity.

Β 

The initial cash consideration of €6.8m (Β£5.7m) will be paid from the Group's existing cash resources. Additional deferred cash consideration of up to €1.7m (Β£1.4m) will be payable in January 2013 subject to the business achieving agreed performance targets over the next two years. Mr W Brack and Ms B Lohmaier will remain with the business and have committed to purchase 61,450 new ordinary shares in Acal plc at 270.5 pence per share, the average mid market closing price for the 5 days up to and including 10 January 2011.

Β 

CompoTRON's revenues for the year ended 31 December 2009 were €7.3m (Β£6.1m) and it generated a pre tax profit of €1.0m (Β£0.8m). Gross assets at 31 December 2009 were €2.2m (Β£1.8m). Forecast revenues for the year ended 31 December 2010 are approximately €10m (Β£8.3m), 37% ahead of the previous year. The acquisition is expected to be earnings enhancing on an underlying profits basis for the Group's year ended 31 March 2011.

Β 

Nick Jefferies, Chief Executive of Acal plc said:

Β 

"The acquisition of CompoTRON is a further step in the implementation of our European specialisation strategy, enhancing our position in the German specialist electronics market. It follows the acquisition of BFi Optilas in December 2009 which has now been successfully integrated into Acal. We are delighted to welcome CompoTRON into the Group."

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

Β 

Cubitt Consulting

Chris Lane/Samantha Boston

01483 544500

Β 

Β 

Β 

020 7367 5100

Β 

Notes to Editors:

Β 

About Acal plc

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic and photonic products to industrial manufacturing and design companies. The Supply Chain Division supplies new and refurbished IT and EPOS spare parts to service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQEANFFFLSFEFF
Date   Source Headline
3rd Jun 20217:00 amRNSPreliminary results
18th May 20219:01 amRNSHolding(s) in Company
10th May 20215:33 pmRNSHolding(s) in Company
20th Apr 20217:00 amRNSFull Year Trading Update
22nd Feb 20215:26 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSAcquisition completion - Limitor GmbH
9th Feb 202112:08 pmRNSHolding(s) in Company
9th Feb 20217:00 amRNSTrading Update
27th Jan 20217:52 amRNSHolding(s) in Company
10th Dec 20208:53 amEQSdiscoverIE Group (DSCV): Another brick in the yellow wall
7th Dec 20204:42 pmRNSHolding(s) in Company
4th Dec 20207:00 amRNSAcquisition of Limitor GmbH
30th Nov 20207:00 amRNSHalf-Year Report
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
23rd Oct 20209:42 amRNSHolding(s) in Company
16th Oct 20201:23 pmRNSHolding(s) in Company
15th Oct 20205:01 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
12th Oct 20209:13 amRNSNOTIFICATION OF MAJOR HOLDINGS
8th Oct 20207:00 amRNSNotice of Trading Update & Half Year Results
26th Aug 20204:03 pmRNSHolding(s) in Company
19th Aug 202012:00 pmRNSResult of AGM
30th Jul 20207:00 amRNSTrading Update
28th Jul 20205:45 pmRNSDirector Declarations
28th Jul 20204:00 pmRNSHolding(s) in Company
27th Jul 202010:00 amRNSHolding(s) in Company
15th Jul 202011:00 amRNSAnnual Report and AGM Notice
14th Jul 202010:00 amRNSHolding(s) in Company
13th Jul 20204:15 pmRNSHolding(s) in Company
13th Jul 20204:00 pmRNSHolding(s) in Company
7th Jul 20209:00 amRNSHolding(s) in Company
3rd Jul 20209:00 amRNSHolding(s) in Company
1st Jul 20205:45 pmRNSDirector LTIP Award
30th Jun 20206:00 pmRNSHolding(s) in Company
30th Jun 20208:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSFinal Results
3rd Jun 20201:24 pmRNSHolding(s) in Company
15th May 20207:00 amRNSYear-end & Covid-19 Trading Update
14th May 20204:05 pmRNSDirector Declaration
21st Apr 20201:00 pmRNSDirector Declaration
14th Apr 202010:19 amRNSHolding(s) in Company
9th Apr 202012:35 pmRNSHolding(s) in Company
7th Apr 20201:45 pmRNSIssue of Equity & Total Voting Rights
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSYear End Trading Update
11th Mar 20203:04 pmRNSHolding(s) in Company
11th Mar 20201:49 pmRNSDirector/PDMR transaction notification
19th Feb 20207:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.